{"id":"W2514523591","doi":"10.1007/s10637-016-0383-2","title":"Adding checkpoint inhibitors to tyrosine kinase inhibitors targeting EGFR/ALK in non-small cell lung cancer: a new therapeutic strategy","year":2016,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Nivolumab; Pembrolizumab; Medicine; Lung cancer; Tyrosine kinase; Erlotinib; EGFR inhibitors; Cancer research; Oncology; Anaplastic lymphoma kinase; Internal medicine; Immunotherapy; Cancer; Epidermal growth factor receptor; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006238709,0.000550566,0.0009212375,0.0005123819,0.0003431845,0.001773484,0.0008379706,0.0008379199,0.005864849],"category_scores_gemma":[0.000517393,0.0002179551,0.0009322203,0.0005009312,0.0005069985,0.002447309,0.0006531872,0.00287984,0.001116011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007773578,"about_ca_system_score_gemma":0.0009474214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004956746,"about_ca_topic_score_gemma":0.002499552,"domain_scores_codex":[0.9997874,0.00003541774,0.00002177529,0.00003888457,0.00006651329,0.00005003159],"domain_scores_gemma":[0.9998124,0.00005515735,0.00003592363,0.00001530279,0.00004395192,0.00003734272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.003095994,0.001411909,0.002059807,0.001073162,0.0001836379,0.0008212978,0.0001677242,0.001623718,0.06013858,0.01629586,0.02372694,0.8894015],"study_design_scores_gemma":[0.006205582,0.01860981,0.01319099,0.001338552,0.001562187,0.007978737,0.0006777116,0.01061613,0.07538855,0.03923076,0.8249488,0.000252142],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2563019,0.5619702,0.02527027,0.0915922,0.007392613,0.0006499441,0.001073636,0.0008144829,0.05493466],"genre_scores_gemma":[0.5808285,0.3422892,0.02158741,0.02111766,0.006071487,0.0003963375,0.0008206768,0.0001583985,0.02673041],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.005864849,"threshold_uncertainty_score":0.01961988,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01607847236170796,"score_gpt":0.2932689510862317,"score_spread":0.2771904787245237,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}